𝔖 Bobbio Scriptorium
✦   LIBER   ✦

First synthesis of a fully active spin-labeled peptide hormone

✍ Scribed by Simone R Barbosa; Eduardo M Cilli; M.Teresa Lamy-Freund; Ana Maria L Castrucci; Clovis R Nakaie

Book ID
117110503
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
102 KB
Volume
446
Category
Article
ISSN
0014-5793

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synthesis and properties of the first al
Synthesis and properties of the first all-aza analogue of a biologically active peptide
✍ Prof. Dr. Joachim Gante; Michael Krug; Günter Lauterbach; Reinhard Weitzel; W. H 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB

The synthesis of the first all-aza-amino acid analogue (2) of a peptidic renin inhibitor is described. The X-ray structural analysis and molecular modelling investigations of this novel compound reveal interesting conformational features which have a significant impact on its biological activity. In

Synthesis and conformational studies of
Synthesis and conformational studies of peptides containing TOAC, a spin-labelled Cα,α-disubstituted glycine
✍ Claudio Toniolo; Ezio Valente; Fernando Formaggio; Marco Crisma; Giuseppe Pillon 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 970 KB

A variety of host L-alanine homo-peptides (to the pentamer) containing one or two spin-labelled TOAC (2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid) residues were synthesized by solution methods and fully characterized. The conformational features of the terminally blocked, doubly s

Hormone-Receptor Interactions. Synthesis
Hormone-Receptor Interactions. Synthesis of a biologically active cysteinyl-angiotensin derivative and its use for the preparation of spin-labelled and polymer-supported molecules
✍ Hans Jörg Möschler; Robert Schwyzer 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 German ⚖ 530 KB

## Abstract (N‐t‐Butoxycarbonyl‐S‐acetamido‐methyl‐L‐cysteinyl)‐[1‐ asparagine, 5‐valine]‐angiotensin II (**2**) was prepared from [1‐asparagine, 5‐valine]‥angiotensin II (**1**). With respect to enhancement of rat blood pressure, it is a full agonist displaying about 20–25% of the potency of **1**